Evaluation of a simple operational approach for monitoring resistance to antimalarial drugs in Peru

Tropical Medicine and International Health

Volumn 8, Issue 10, 2003, Pages 910-916

  Ruebush, Trenton K ^a,b,e   Levin, Andrew ^b,f   Gonzaga, Victor ^b   Neyra, Daniel ^c,f   Marquiño, Wilmer ^d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b California   (Peru)

^c Prog Contr Malaria Otras E   (Peru)

^d INSTITUTO NACIONAL DE SALUD   (Peru)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Bldg 16 352 ^*  (Peru)

Author keywords

Antimalarial drug resistance; Peru; Surveillance

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

DISEASE CONTROL; DRUG PRESCRIBING; DRUG RESISTANCE; MALARIA;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SMEAR; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; DRUG SCREENING; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; PARASITEMIA; PERU; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; CHLOROQUINE; DRUG COMBINATIONS; DRUG MONITORING; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PERU; PYRIMETHAMINE; QUALITY OF HEALTH CARE; SULFADOXINE; TREATMENT FAILURE;

PERU;

PLASMODIUM FALCIPARUM;

EID: 0142184473     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01106.x     Document Type: Article

References (9)

1. Baird JK, Leksana B, Masbar S et al. (1997) Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. American Journal of Tropical Medicine and Hygiene 56, 621-626.
2. Barat LM, Himonga B, Nkunika S et al. (1998) A systematic approach to the development of a rational malaria treatment policy in Zambia. Tropical Medicine and International Health 3, 535-542.
3. East Africa Network for Monitoring Antimalarial Treatment (2001) Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Tropical Medicine and International Health 6, 1-8.
4. Fryauff DJ, Tuti S, Mardi A et al. (1998) Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. American Journal of Tropical Medicine and Hygiene 59, 513-518.
5. Marquiño W, MacArthur JR, Barat LM et al. (2000) Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. American Journal of Tropical Medicine and Hygiene 68, 120-123.
6. Pan American Health Organization (1998) Evaluation of the Therapeutic Efficacy of Drugs for the Treatment of Uncomplicated Plasmodium falciparum Malaria in the Americas. OPS/HCP/HCT/113/98. PAHO, Washington, DC.
7. Programa de Control de la Malaria y Otras Enfermedades Metaxénicas (1994) Doctrina, Normas y Procedimientos para el Control de la Malaria en Perú. Ministerio de Salud, Lima.
8. Ruebush TK, Marquino W, Zegarra J et al. (2003) Practical aspects of in vivo antimalarial drug efficacy testing in the Americas. American Journal of Tropical Medicine and Hygiene 68, 391-393.
9. WHO (1996) Assessment of Therapeutic Efficacy to Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. (WHO/MAL/96.1007) WHO, Geneva.